TD Waterhouse Canada’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.56M Buy
65,219
+7,584
+13% +$530K 0.03% 291
2025
Q1
$3.92M Sell
57,635
-54,195
-48% -$3.68M 0.03% 295
2024
Q4
$9.62M Sell
111,830
-90,868
-45% -$7.81M 0.08% 192
2024
Q3
$23.9M Buy
202,698
+14,447
+8% +$1.7M 0.19% 102
2024
Q2
$27.4M Buy
188,251
+57,850
+44% +$8.43M 0.25% 83
2024
Q1
$19.9M Buy
130,401
+34,738
+36% +$5.31M 0.15% 121
2023
Q4
$12.5M Buy
95,663
+25,109
+36% +$3.29M 0.12% 138
2023
Q3
$7.77M Buy
70,554
+21,140
+43% +$2.33M 0.08% 166
2023
Q2
$4.07M Sell
49,414
-16,756
-25% -$1.38M 0.04% 237
2023
Q1
$5.48M Sell
66,170
-1,214
-2% -$101K 0.06% 195
2022
Q4
$4.8M Sell
67,384
-1,292
-2% -$92.1K 0.05% 200
2022
Q3
$3.65M Sell
68,676
-3,488
-5% -$186K 0.04% 224
2022
Q2
$4.12M Buy
72,164
+2,162
+3% +$123K 0.05% 220
2022
Q1
$4.04M Sell
70,002
-24,980
-26% -$1.44M 0.04% 241
2021
Q4
$5.11M Buy
+94,982
New +$5.11M 0.05% 216